These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18075500)

  • 1. Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis.
    Petersen M; Thorikay M; Deckers M; van Dinther M; Grygielko ET; Gellibert F; de Gouville AC; Huet S; ten Dijke P; Laping NJ
    Kidney Int; 2008 Mar; 73(6):705-15. PubMed ID: 18075500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of TGF-β1 Receptor Inhibitor GW788388 on the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells.
    Lho Y; Do JY; Heo JY; Kim AY; Kim SW; Kang SH
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33947038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells.
    Shinto O; Yashiro M; Kawajiri H; Shimizu K; Shimizu T; Miwa A; Hirakawa K
    Br J Cancer; 2010 Mar; 102(5):844-51. PubMed ID: 20145621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
    Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK
    Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction.
    Tan SM; Zhang Y; Connelly KA; Gilbert RE; Kelly DJ
    Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1415-25. PubMed ID: 20154262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of p38 mitogen-activated protein kinase and transforming growth factor-beta1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy.
    Li J; Campanale NV; Liang RJ; Deane JA; Bertram JF; Ricardo SD
    Am J Pathol; 2006 Nov; 169(5):1527-40. PubMed ID: 17071578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Src activation is not necessary for transforming growth factor (TGF)-beta-mediated epithelial to mesenchymal transitions (EMT) in mammary epithelial cells. PP1 directly inhibits TGF-beta receptors I and II.
    Maeda M; Shintani Y; Wheelock MJ; Johnson KR
    J Biol Chem; 2006 Jan; 281(1):59-68. PubMed ID: 16267045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of 4-{4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}-N-(tetrahydro-2H- pyran-4-yl)benzamide (GW788388): a potent, selective, and orally active transforming growth factor-beta type I receptor inhibitor.
    Gellibert F; de Gouville AC; Woolven J; Mathews N; Nguyen VL; Bertho-Ruault C; Patikis A; Grygielko ET; Laping NJ; Huet S
    J Med Chem; 2006 Apr; 49(7):2210-21. PubMed ID: 16570917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors.
    Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
    Curr Cancer Drug Targets; 2011 May; 11(4):524-35. PubMed ID: 21395548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
    Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
    Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta stimulates intestinal epithelial focal adhesion kinase synthesis via Smad- and p38-dependent mechanisms.
    Walsh MF; Ampasala DR; Hatfield J; Vander Heide R; Suer S; Rishi AK; Basson MD
    Am J Pathol; 2008 Aug; 173(2):385-99. PubMed ID: 18583311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b.
    Wang B; Jha JC; Hagiwara S; McClelland AD; Jandeleit-Dahm K; Thomas MC; Cooper ME; Kantharidis P
    Kidney Int; 2014 Feb; 85(2):352-61. PubMed ID: 24088962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Klotho attenuates high glucose-induced fibronectin and cell hypertrophy via the ERK1/2-p38 kinase signaling pathway in renal interstitial fibroblasts.
    Huang JS; Chuang CT; Liu MH; Lin SH; Guh JY; Chuang LY
    Mol Cell Endocrinol; 2014 Jun; 390(1-2):45-53. PubMed ID: 24721634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor.
    Bonniaud P; Margetts PJ; Kolb M; Schroeder JA; Kapoun AM; Damm D; Murphy A; Chakravarty S; Dugar S; Higgins L; Protter AA; Gauldie J
    Am J Respir Crit Care Med; 2005 Apr; 171(8):889-98. PubMed ID: 15563636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells.
    Zhang J; Thorikay M; van der Zon G; van Dinther M; Ten Dijke P
    J Vis Exp; 2020 Oct; (164):. PubMed ID: 33191940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis.
    Higashiyama H; Yoshimoto D; Kaise T; Matsubara S; Fujiwara M; Kikkawa H; Asano S; Kinoshita M
    Exp Mol Pathol; 2007 Aug; 83(1):39-46. PubMed ID: 17274978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive Smad signaling and Smad-dependent collagen gene expression in mouse embryonic fibroblasts lacking peroxisome proliferator-activated receptor-gamma.
    Ghosh AK; Wei J; Wu M; Varga J
    Biochem Biophys Res Commun; 2008 Sep; 374(2):231-6. PubMed ID: 18627765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
    Laping NJ; Grygielko E; Mathur A; Butter S; Bomberger J; Tweed C; Martin W; Fornwald J; Lehr R; Harling J; Gaster L; Callahan JF; Olson BA
    Mol Pharmacol; 2002 Jul; 62(1):58-64. PubMed ID: 12065755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo.
    Wang S; Wilkes MC; Leof EB; Hirschberg R
    FASEB J; 2005 Jan; 19(1):1-11. PubMed ID: 15629889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.